HFA Premium Access

HFpEF and HFrEF display different anabolic phenotypes as assessed by IGF-1 and IGFBP-1

Topic: HFpEF - Heart failure with preserved ejection fraction

Congress Presentation

About the speaker

Doctor Ulrika Ljung Faxen

Karolinska Institute, Stockholm (Sweden)
0 follower

4 more presentations in this session

HfpEF 2020: opportunities to intervene

Speaker: Professor R. De Boer (Rotterdam, NL)


Na+/Ca2+ Exchanger (NCX) inhibition with ORM 11035 improves cardiac function and remodeling without lowering blood pressure in a model of heart failure with preserved ejection fraction

Speaker: Professor F. Heinzel (Berlin, DE)


A restrictive pattern of LV filling is only present in one third of cardiac AL amyloidosis patients

Speaker: Associate Professor S. Perlini (Pavia, IT)


Dipeptidyl peptidase 4 inhibitor sitagliptin reduces oxidative stress, endothelial dysfunction and preserves diastolic function in a rat model of heart failure with preserved ejection fraction

Speaker: Doctor K. Urbanek (Naples, IT)


Access the full session

Directions in HFpEF research

Speakers: Doctor U. Ljung Faxen, Professor R. De Boer, Professor F. Heinzel, Associate Professor S. Perlini, Doctor K. Urbanek

About the event



21 May - 24 May 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb